Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2011
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in AfricaKim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 20, 2015
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230Nagalingeswaran Kumarasamy, Evgenia Aga, Heather J Ribaudo, et al.
The Journal of Infectious Diseases|March 27, 2012
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan AfricaKim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance networkRaph L Hamers, Elske Straatsma, Cissy Kityo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategiesRaph L Hamers, Kim C E Sigaloff, Annemarie M Wensing, et al.
AIDS (London, England)|March 24, 2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsJohn A Bartlett, Heather J Ribaudo, Carole L Wallis, et al.
The Lancet. Global Health|July 19, 2015
Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIFGavin J Churchyard, Wendy S Stevens, Lerole D Mametja, et al.
Plos One|September 22, 2010
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission riskJairam R Lingappa, James P Hughes, Richard S Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countriesKim C E Sigaloff, Raph L Hamers, Jack Menke, et al.
The Lancet. Infectious Diseases|November 1, 2011
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyRaph L Hamers, Rob Schuurman, Kim C E Sigaloff, et al.
Pageof 8